TIPARP and breast cancer: GSPT2, SAMD4A, and TIPARP are downregulated in ECM-receptor interaction pathways, which play important roles in tumor shedding, adhesion, degradation, motility, and proliferation and may be involved in breast cancer development (Bao et al., 2019).